CONDENSED STATEMENT OF CASH FLOWS	7 Months Ended
	Sep. 30, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (375,828)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on investments held in Trust Account	(3,870)
Changes in current assets and liabilities:
Due to related parties	31,332
Prepaid expense	(1,854,827)
Accrued offering costs and expenses	10,300
Net cash used in operating activities	(2,192,893)
Cash Flows from Investing Activities:
Principal deposited in Trust Account	(255,425,373)
Net cash used in investing activities	(255,425,373)
Cash Flows from Financing Activities:
Proceeds received from public offerings, net of underwriters' discount	254,316,863
Proceeds from private placement	3,108,510
Proceeds from working capital loan	1,000,000
Payment of deferred offering costs	(420,997)
Payment of promissory note to related party	(163,205)
Net cash provided by financing activities	257,841,171
Net change in cash	222,905
Cash, March 16, 2021 (inception)	0
Cash, end of the period	222,905
Supplemental disclosure of cash flow information:
Deferred underwriter's discount	1,939,888
Initial value of Class A ordinary shares subject to possible redemption	250,000,000
Remeasurement of Class A ordinary shares subject to possible redemption	5,429,243
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	25,000
Deferred offering costs paid by Sponsor under the promissory note	$ 163,205